首页> 美国卫生研究院文献>Medical Journal of the Islamic Republic of Iran >Anti-hemorrhagic activity of Punica granatum L. flower (Persian Golnar) against heavy menstrual bleeding of endometrial origin: a double-blind randomized controlled trial
【2h】

Anti-hemorrhagic activity of Punica granatum L. flower (Persian Golnar) against heavy menstrual bleeding of endometrial origin: a double-blind randomized controlled trial

机译:石榴(Punica granatum L. flower)(波斯Golnar)对子宫内膜起源的大月经出血的止血作用:一项双盲随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Heavy menstrual bleeding of endometrial origin (HMB) is a major healthcare problem in premenopausal women and affects several aspects of women’s health and quality of life (QoL). The aim of this study was to compare the efficacy of Persian Golnar (PG) and tranexamic acid (TA) on heavy menstrual bleeding of endometrial origin (HMB) and patients’ QoL. >Methods: A double-blind randomized controlled trial with parallel design and block randomization technique was conducted. A total of 94 women with HMB were randomly assigned to take either PG or TA for 5 days from day 1 of menses for three consecutive menstrual cycles. Blood loss was measured by the pictorial blood loss assessment chart (PBAC). Hematological assessments were made before the intervention and after treatment. QoL as a secondary outcome was evaluated using SF-36 and the menorrhagia questionnaire (MQ). Statistical analysis was performed using t-test, paired ttest, χ2 test, Mann–Whitney test, and Wilcoxon signed-rank test. >Results: In each group, 38 women (80.8%) completed the 3-month follow-up. Both PG and TA reduced blood loss. PBAC mean (SD) score was reduced from 304.92 (176.17) and 304.44 (192.72) to 164.60 (100.24) and 143.13 (96.07) after the third treatment cycle, respectively (p< 0.001). Furthermore,mean hemoglobin, Hb (SD) concentrations in the PG and TA groups increased significantlyfrom 12.06 (0.86) and 11.53 (0.86)mg/dl to 13.02 (0.82) and 12.72 (0.88) mg/dl (p< 0.001). QoLwas significantly improved in both groups (p< 0.001). However, there were no significant differencesbetween the groups after the intervention.>Conclusion: The results of the present study demonstrate the efficacy of PG in treating HMB interms of clinical and QoL indicators.
机译:>背景:子宫内膜起源的大量月经出血(HMB)是绝经前女性的主要医疗保健问题,并且会影响女性健康和生活质量(QoL)的多个方面。这项研究的目的是比较波斯Golnar(PG)和氨甲环酸(TA)对子宫内膜起源(HMB)和患者QoL的严重经期出血的疗效。 >方法:进行了具有并行设计和分组随机技术的双盲随机对照试验。从月经的第一天起,总共有94名HMB妇女被随机分配接受PG或TA连续5天,连续三个月经周期。出血量通过图片的失血量评估图(PBAC)进行测量。在干预之前和治疗之后进行血液学评估。使用SF-36和月经过多问卷(MQ)对QoL作为次要结果进行了评估。使用t检验,配对t检验,χ2检验,Mann-Whitney检验和Wilcoxon秩和检验进行统计分析。 >结果:在每个组中,有38名妇女(80.8%)完成了为期3个月的随访。 PG和TA均可减少失血量。在第三个治疗周期后,PBAC平均值(SD)评分分别从304.92(176.17)和304.44(192.72)降至164.60(100.24)和143.13(96.07)(p <0.001)。此外,PG和TA组的平均血红蛋白,Hb(SD)浓度显着增加从12.06(0.86)和11.53(0.86)mg / dl到13.02(0.82)和12.72(0.88)mg / dl(p <0.001)。生活质量两组均显着改善(p <0.001)。但是,没有显着差异干预后各组之间。>结论:本研究的结果证明了PG治疗HMB的疗效。临床和生活质量指标方面。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号